EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dynamic Muscle Atrophy Predicts Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Lenvatinib: A Retrospective Study in Taiwan

Hsing-Yun Lee, Ching-Di Chang iD, Yen-Hao Chen iD, Ming-Chao Tsai iD, Jing-Houng Wang iD, Sheng-Nan Lu iD, Tsung-Hui Hu iD, Chao-Hung Hung iD, Chien-Hung Chen iD, Yuan-Hung Kuo iD

Gut and Liver · 2025

DOI: 10.5009/gnl250073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gut and Liver, 2025. Verfasst von Hsing-Yun Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatogastroenterology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Phenylurea Compounds, Quinolines. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chang Gung Memorial Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsPhenylurea CompoundsQuinolinesMuscular AtrophyAntineoplastic AgentsHumansFemaleMaleRetrospective StudiesMiddle AgedAgedTaiwanPropensity ScorePsoas MusclesTreatment OutcomePrognosis

Stichwörter der Autor:innen

Carcinoma, hepatocellularLenvatinibMuscle atrophyPsoas musclesSarcopenia

Substanzen

lenvatinibPhenylurea CompoundsQuinolinesAntineoplastic Agents

Autor:innen und Institutionen

  • Division of Hepatogastroenterology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
  • Division of Radiology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
  • Division of Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

ORCID-Profile: Ching-Di Chang, Yen-Hao Chen, Ming-Chao Tsai, Jing-Houng Wang, Sheng-Nan Lu, Tsung-Hui Hu, Chao-Hung Hung, Chien-Hung Chen, Yuan-Hung Kuo

Förderung

  • Chang Gung Memorial Hospital

Zitieren

APA

Lee, H. Y., Chang, C. D., Chen, Y. H., Tsai, M. C., Wang, J. H., Lu, S. N., Hu, T. H., Hung, C. H., Chen, C. H., & Kuo, Y. H. (2025). Dynamic Muscle Atrophy Predicts Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Lenvatinib: A Retrospective Study in Taiwan. Gut and Liver. https://doi.org/10.5009/gnl250073

Vancouver

Lee HY, Chang CD, Chen YH, Tsai MC, Wang JH, Lu SN, et al. Dynamic Muscle Atrophy Predicts Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Lenvatinib: A Retrospective Study in Taiwan. Gut and Liver. 2025. doi:10.5009/gnl250073

BibTeX
@article{Lee2025,
  author = {Lee, Hsing-Yun and Chang, Ching-Di and Chen, Yen-Hao and Tsai, Ming-Chao and Wang, Jing-Houng and Lu, Sheng-Nan and Hu, Tsung-Hui and Hung, Chao-Hung and Chen, Chien-Hung and Kuo, Yuan-Hung},
  title = {Dynamic Muscle Atrophy Predicts Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Lenvatinib: A Retrospective Study in Taiwan},
  journal = {Gut and Liver},
  year = {2025},
  doi = {10.5009/gnl250073}
}
Kostenlos starten →